Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin

Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality

(2021) William R. Morgenlander et al.   JOURNAL OF CLINICAL INVESTIGATION

Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19

(2020) Kumaragurubaran Karthik et al.   Human Vaccines & Immunotherapeutics

Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?

(2020) Alberto Beretta et al.   Frontiers in Immunology

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

(2020) Wen Shi Lee et al.   Nature Microbiology

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity

(2020) Carolin Loos et al.   mSphere

ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis

(2020) Maryse Cloutier et al.   CYTOKINE

High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa

(2020) For Yue Tso et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Coronavirus Receptors as Immune Modulators

(2020) Charan Kumar V. Devarakonda et al.   JOURNAL OF IMMUNOLOGY

HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic

(2020) Elena Rita Simula et al.   Microorganisms